Cargando…
Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225]
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Science Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854447/ https://www.ncbi.nlm.nih.gov/pubmed/29248309 http://dx.doi.org/10.1016/j.ejca.2017.11.017 |
| _version_ | 1783470215865040896 |
|---|---|
| author | Gnekow, Astrid K. Walker, David A. Kandels, Daniela Picton, Susan Giorgio Perilongo Grill, Jacques Stokland, Tore Sandstrom, Per Eric Warmuth-Metz, Monika Pietsch, Torsten Giangaspero, Felice Schmidt, René Faldum, Andreas Kilmartin, Denise De Paoli, Angela De Salvo, Gian Luca |
| author_facet | Gnekow, Astrid K. Walker, David A. Kandels, Daniela Picton, Susan Giorgio Perilongo Grill, Jacques Stokland, Tore Sandstrom, Per Eric Warmuth-Metz, Monika Pietsch, Torsten Giangaspero, Felice Schmidt, René Faldum, Andreas Kilmartin, Denise De Paoli, Angela De Salvo, Gian Luca |
| author_sort | Gnekow, Astrid K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6854447 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Elsevier Science Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68544472019-11-20 Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225] Gnekow, Astrid K. Walker, David A. Kandels, Daniela Picton, Susan Giorgio Perilongo Grill, Jacques Stokland, Tore Sandstrom, Per Eric Warmuth-Metz, Monika Pietsch, Torsten Giangaspero, Felice Schmidt, René Faldum, Andreas Kilmartin, Denise De Paoli, Angela De Salvo, Gian Luca Eur J Cancer Article Elsevier Science Ltd 2018-02 /pmc/articles/PMC6854447/ /pubmed/29248309 http://dx.doi.org/10.1016/j.ejca.2017.11.017 Text en © 2017 University of Nottingham http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Article Gnekow, Astrid K. Walker, David A. Kandels, Daniela Picton, Susan Giorgio Perilongo Grill, Jacques Stokland, Tore Sandstrom, Per Eric Warmuth-Metz, Monika Pietsch, Torsten Giangaspero, Felice Schmidt, René Faldum, Andreas Kilmartin, Denise De Paoli, Angela De Salvo, Gian Luca Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225] |
| title | Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225] |
| title_full | Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225] |
| title_fullStr | Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225] |
| title_full_unstemmed | Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225] |
| title_short | Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225] |
| title_sort | corrigendum to “a european randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – a final report” [eur j of canc (2017) 206–225] |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854447/ https://www.ncbi.nlm.nih.gov/pubmed/29248309 http://dx.doi.org/10.1016/j.ejca.2017.11.017 |
| work_keys_str_mv | AT gnekowastridk corrigendumtoaeuropeanrandomisedcontrolledtrialoftheadditionofetoposidetostandardvincristineandcarboplatininductionaspartofan18monthtreatmentprogrammeforchildhood16yearslowgradegliomaafinalreporteurjofcanc2017206225 AT walkerdavida corrigendumtoaeuropeanrandomisedcontrolledtrialoftheadditionofetoposidetostandardvincristineandcarboplatininductionaspartofan18monthtreatmentprogrammeforchildhood16yearslowgradegliomaafinalreporteurjofcanc2017206225 AT kandelsdaniela corrigendumtoaeuropeanrandomisedcontrolledtrialoftheadditionofetoposidetostandardvincristineandcarboplatininductionaspartofan18monthtreatmentprogrammeforchildhood16yearslowgradegliomaafinalreporteurjofcanc2017206225 AT pictonsusan corrigendumtoaeuropeanrandomisedcontrolledtrialoftheadditionofetoposidetostandardvincristineandcarboplatininductionaspartofan18monthtreatmentprogrammeforchildhood16yearslowgradegliomaafinalreporteurjofcanc2017206225 AT giorgioperilongo corrigendumtoaeuropeanrandomisedcontrolledtrialoftheadditionofetoposidetostandardvincristineandcarboplatininductionaspartofan18monthtreatmentprogrammeforchildhood16yearslowgradegliomaafinalreporteurjofcanc2017206225 AT grilljacques corrigendumtoaeuropeanrandomisedcontrolledtrialoftheadditionofetoposidetostandardvincristineandcarboplatininductionaspartofan18monthtreatmentprogrammeforchildhood16yearslowgradegliomaafinalreporteurjofcanc2017206225 AT stoklandtore corrigendumtoaeuropeanrandomisedcontrolledtrialoftheadditionofetoposidetostandardvincristineandcarboplatininductionaspartofan18monthtreatmentprogrammeforchildhood16yearslowgradegliomaafinalreporteurjofcanc2017206225 AT sandstrompereric corrigendumtoaeuropeanrandomisedcontrolledtrialoftheadditionofetoposidetostandardvincristineandcarboplatininductionaspartofan18monthtreatmentprogrammeforchildhood16yearslowgradegliomaafinalreporteurjofcanc2017206225 AT warmuthmetzmonika corrigendumtoaeuropeanrandomisedcontrolledtrialoftheadditionofetoposidetostandardvincristineandcarboplatininductionaspartofan18monthtreatmentprogrammeforchildhood16yearslowgradegliomaafinalreporteurjofcanc2017206225 AT pietschtorsten corrigendumtoaeuropeanrandomisedcontrolledtrialoftheadditionofetoposidetostandardvincristineandcarboplatininductionaspartofan18monthtreatmentprogrammeforchildhood16yearslowgradegliomaafinalreporteurjofcanc2017206225 AT giangasperofelice corrigendumtoaeuropeanrandomisedcontrolledtrialoftheadditionofetoposidetostandardvincristineandcarboplatininductionaspartofan18monthtreatmentprogrammeforchildhood16yearslowgradegliomaafinalreporteurjofcanc2017206225 AT schmidtrene corrigendumtoaeuropeanrandomisedcontrolledtrialoftheadditionofetoposidetostandardvincristineandcarboplatininductionaspartofan18monthtreatmentprogrammeforchildhood16yearslowgradegliomaafinalreporteurjofcanc2017206225 AT faldumandreas corrigendumtoaeuropeanrandomisedcontrolledtrialoftheadditionofetoposidetostandardvincristineandcarboplatininductionaspartofan18monthtreatmentprogrammeforchildhood16yearslowgradegliomaafinalreporteurjofcanc2017206225 AT kilmartindenise corrigendumtoaeuropeanrandomisedcontrolledtrialoftheadditionofetoposidetostandardvincristineandcarboplatininductionaspartofan18monthtreatmentprogrammeforchildhood16yearslowgradegliomaafinalreporteurjofcanc2017206225 AT depaoliangela corrigendumtoaeuropeanrandomisedcontrolledtrialoftheadditionofetoposidetostandardvincristineandcarboplatininductionaspartofan18monthtreatmentprogrammeforchildhood16yearslowgradegliomaafinalreporteurjofcanc2017206225 AT desalvogianluca corrigendumtoaeuropeanrandomisedcontrolledtrialoftheadditionofetoposidetostandardvincristineandcarboplatininductionaspartofan18monthtreatmentprogrammeforchildhood16yearslowgradegliomaafinalreporteurjofcanc2017206225 AT corrigendumtoaeuropeanrandomisedcontrolledtrialoftheadditionofetoposidetostandardvincristineandcarboplatininductionaspartofan18monthtreatmentprogrammeforchildhood16yearslowgradegliomaafinalreporteurjofcanc2017206225 |